KEGG   Talpa occidentalis (Iberian mole): 119252397
Entry
119252397         CDS       T07495                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
tod  Talpa occidentalis (Iberian mole)
Pathway
tod01522  Endocrine resistance
tod01524  Platinum drug resistance
tod04012  ErbB signaling pathway
tod04066  HIF-1 signaling pathway
tod04068  FoxO signaling pathway
tod04110  Cell cycle
tod04115  p53 signaling pathway
tod04151  PI3K-Akt signaling pathway
tod04218  Cellular senescence
tod04630  JAK-STAT signaling pathway
tod04921  Oxytocin signaling pathway
tod04928  Parathyroid hormone synthesis, secretion and action
tod04934  Cushing syndrome
tod05160  Hepatitis C
tod05161  Hepatitis B
tod05163  Human cytomegalovirus infection
tod05165  Human papillomavirus infection
tod05166  Human T-cell leukemia virus 1 infection
tod05167  Kaposi sarcoma-associated herpesvirus infection
tod05169  Epstein-Barr virus infection
tod05200  Pathways in cancer
tod05202  Transcriptional misregulation in cancer
tod05203  Viral carcinogenesis
tod05205  Proteoglycans in cancer
tod05206  MicroRNAs in cancer
tod05210  Colorectal cancer
tod05211  Renal cell carcinoma
tod05212  Pancreatic cancer
tod05213  Endometrial cancer
tod05214  Glioma
tod05215  Prostate cancer
tod05216  Thyroid cancer
tod05217  Basal cell carcinoma
tod05218  Melanoma
tod05219  Bladder cancer
tod05220  Chronic myeloid leukemia
tod05222  Small cell lung cancer
tod05223  Non-small cell lung cancer
tod05224  Breast cancer
tod05225  Hepatocellular carcinoma
tod05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:tod00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    119252397 (CDKN1A)
   04630 JAK-STAT signaling pathway
    119252397 (CDKN1A)
   04066 HIF-1 signaling pathway
    119252397 (CDKN1A)
   04068 FoxO signaling pathway
    119252397 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    119252397 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    119252397 (CDKN1A)
   04115 p53 signaling pathway
    119252397 (CDKN1A)
   04218 Cellular senescence
    119252397 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    119252397 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    119252397 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    119252397 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    119252397 (CDKN1A)
   05206 MicroRNAs in cancer
    119252397 (CDKN1A)
   05205 Proteoglycans in cancer
    119252397 (CDKN1A)
   05203 Viral carcinogenesis
    119252397 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    119252397 (CDKN1A)
   05212 Pancreatic cancer
    119252397 (CDKN1A)
   05225 Hepatocellular carcinoma
    119252397 (CDKN1A)
   05226 Gastric cancer
    119252397 (CDKN1A)
   05214 Glioma
    119252397 (CDKN1A)
   05216 Thyroid cancer
    119252397 (CDKN1A)
   05220 Chronic myeloid leukemia
    119252397 (CDKN1A)
   05217 Basal cell carcinoma
    119252397 (CDKN1A)
   05218 Melanoma
    119252397 (CDKN1A)
   05211 Renal cell carcinoma
    119252397 (CDKN1A)
   05219 Bladder cancer
    119252397 (CDKN1A)
   05215 Prostate cancer
    119252397 (CDKN1A)
   05213 Endometrial cancer
    119252397 (CDKN1A)
   05224 Breast cancer
    119252397 (CDKN1A)
   05222 Small cell lung cancer
    119252397 (CDKN1A)
   05223 Non-small cell lung cancer
    119252397 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    119252397 (CDKN1A)
   05161 Hepatitis B
    119252397 (CDKN1A)
   05160 Hepatitis C
    119252397 (CDKN1A)
   05163 Human cytomegalovirus infection
    119252397 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    119252397 (CDKN1A)
   05169 Epstein-Barr virus infection
    119252397 (CDKN1A)
   05165 Human papillomavirus infection
    119252397 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    119252397 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    119252397 (CDKN1A)
   01522 Endocrine resistance
    119252397 (CDKN1A)
SSDB
Motif
Pfam: CDI E_raikovi_mat
Other DBs
NCBI-GeneID: 119252397
NCBI-ProteinID: XP_037375507
LinkDB
Position
Unknown
AA seq 159 aa
MPEPSGDTRPIPRGSKACRRLFGPVDSEQLRQDCDAAMASCVQEACERWNFDFVTETPLE
GDFAWERVRGLGLPKFYLGGRDDLGGSKRPGTSSALLQGTAQEDHVDLSLSCTILPHTPE
RPEASPGGSGTSQGRKRRQTSMTDFYHSKRRLIFSKRKP
NT seq 480 nt   +upstreamnt  +downstreamnt
atgccagagccgtcaggagatacccgtcccatcccaaggggcagcaaggcatgccgccgc
ctctttggcccggtggacagtgagcagctccgccaggattgcgatgcagcaatggccagc
tgtgtgcaggaggcctgtgagcggtggaacttcgactttgtcaccgagacaccactggaa
ggcgacttcgcctgggagcgcgtgcggggcctcggcctgcccaagttctacctggggggc
cgggacgacctaggagggagcaagcggcctggcacctcatccgccctgttgcaggggaca
gctcaggaggaccacgtggacctgtcgctatcttgcaccatcctgcctcacacccctgag
cgccctgaagcttcccctggtgggtctggaacctctcagggccgaaaacggaggcagacc
agcatgacagatttctatcactctaaacgccggctgatcttctccaagaggaagccctaa

DBGET integrated database retrieval system